Last reviewed · How we verify
NCT05536388
Drug Discovery for Parkinson's With Mutations in the GBA Gene
trial testing Biological Sample Collection in Parkinson Disease in 60 participants. Currently enrolling.
15 July 2025
Quick facts
| Lead sponsor | New York Stem Cell Foundation Research Institute |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 15 July 2022 |
| Primary completion | 15 July 2025 |
| Estimated completion | 15 July 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Biological Sample Collection — full drug profile →
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
- Gaucher Disease — all drugs for Gaucher Disease →
- Healthy — all drugs for Healthy →
- GBA Gene Mutation — all drugs for GBA Gene Mutation →
Sponsor
New York Stem Cell Foundation Research Institute
Who can join
18 and older, any sex, with Parkinson Disease or Gaucher Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate Parkinson's disease research and drug development by using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for Parkinson's disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05536388
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Biological Sample Collection
Trials testing the same drug.
- NCT07398430 — Metabolic Characteristics and Prognostic Model of Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea · not yet recruiting
- NCT06350539 — Personalized Models for Cancer Research · recruiting
- NCT06203106 — NYSCF Scientific Discovery Biobank · recruiting
- NCT06203093 — Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking · recruiting
- NCT04387955 — Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID) · NA · completed
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other New York Stem Cell Foundation Research Institute trials
Trials by the same sponsor.
- NCT06350539 — Personalized Models for Cancer Research · recruiting
- NCT06203106 — NYSCF Scientific Discovery Biobank · recruiting
- NCT06203093 — Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking · recruiting
- NCT04270604 — Biological Sample Collection for Research and Biobanking · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05536388 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by New York Stem Cell Foundation Research Institute
- Last refreshed: 3 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05536388.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing